Project description
Novel test for detecting obstructive sleep apnoea
Obstructive sleep apnoea (OSA) is a condition associated with the collapse of the upper airway during sleep. It is caused by the excessive relaxation of the muscles that support the throat and tongue. Diagnosis involves spending the night in a sleep laboratory and undergoing a polysomnography test. Scientists of the EU-funded Sleepwise project have developed a less intrusive approach for detecting OSA as well as other sleep-related disorders and epilepsy. The test relies on image processing during sleep/awake periods, does not require extensive training, and importantly, it is suitable for use in children.
Objective
The Obstructive Sleep Apnea (OSA) is a chronic disease that afflicts approximately 100 million people, however, nearly 80%
of people with this condition remain undiagnosed. Sleep Apnea has serious medical consequences but it is also
economically costly. In the USA alone the estimated economic cost of undiagnosed OSA is $149.6 billion.
The diagnosis of OSA is typically made after a polysomnography (PSG), an expensive test that requires an overnight stay in
a sleep laboratory wired to up to 15 different devices. Today the use of Home Sleep Tests are increasing due to are less
intrusive and cheaper, however, they are subject to patient error in attaching the sensors, require previous training, are
cumbersome and are not appropriate for children.
Tarsio Medics is a technological company that has been working during more than 10 years together with the Pneumology
unit of the Hospital Trias i Pujol to develop SleepWise, an innovative system for the exploration and diagnosis of OSA based
on image processing.
Our patented SleepWise system is non-intrusive, low cost, does not require training. It provides automatic analysis for sleep
professionals, is more reliable because it can infer sleep/awake periods and is more versatile as it can also detect other
nocturnal movements such as restless legs, parasomnias and epilepsy.
We plan to monetize SleepWise offering a complete end-to-end service to doctors, hospitals and health insurance
companies. The market potential is large: the global sleep apnea diagnostic system market is €341.7 €205.06 of them
related with Home Sleep Tests.
Currently we have a beta version of the SleepWise. Now we are applying to the SME Instrument Phase 1 to carry out a
Feasibility Study to assess operational, technological and economic viability as well as to elaborate a Business Plan to
define the business growth, sustainability, exploitation strategies and tactics to follow paving the way to a global market.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesclinical medicinepsychiatrysleep disorders
- medical and health sciencesclinical medicinepneumology
- medical and health sciencesbasic medicineneurologyepilepsy
- social scienceseconomics and businessbusiness and managementbusiness models
- engineering and technologymedical engineeringdiagnostic imaging
You need to log in or register to use this function
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
08380 MALGRAT DE MAR
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.